One year after becoming the first centre to open a global clinical trial of a radioligand therapy for metastatic prostate ...

Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, especially the most malignant proximal-proliferative subtype without ...